← Eichor
Study identifier: NCT07310797 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion

Condition: Ureteral Calculi  ·  Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

PhasePhase 4
Planned participants500
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This randomized controlled trial compares the efficacy and safety of four treatment strategies for ureteral stone expulsion: Mirabegron alone, Tamsulosin alone, a combination of both, and standard conservative care. Participants diagnosed with ureteral stones will be randomly assigned to one of these four groups. The primary objective is to evaluate the stone expulsion rate within 4 weeks. The study also assesses time to expulsion, pain intensity, analgesic use, and potential side effects.

This description comes directly from the study's public registry record.

Talk to the study team

Shu-Yu Wu, Doctor of Medicine  ·  +886-2-6628-9779  ·  nobookrain2014@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Taipei Tzu Chi HospitalNew Taipei City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07310797